ISSN: 1476-0584

Journal Home

Journal Guideline

Expert Review of Vaccines Q1 Unclaimed

Taylor and Francis Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Review of Vaccines is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 105. It has a price of 4000 €. It has an SJR impact factor of 1,412 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,412.

Expert Review of Vaccines focuses its scope in these topics and keywords: vaccines, vaccine, diseases, neglected, pcv, hiv, iii, immunoinformatics, impact, designplantbased, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q1) Immunology (Q1) Molecular Medicine (Q1) Pharmacology (Q1)

Price

4000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,412

SJR Impact factor

105

H Index

110

Total Docs (Last Year)

409

Total Docs (3 years)

7915

Total Refs

2013

Total Cites (3 years)

364

Citable Docs (3 years)

5.1

Cites/Doc (2 years)

71.95

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Protein & Cell Q1
Molecular Therapy Q1
Nature Reviews Drug Discovery Q1
Medicinal Research Reviews Q1
Cell Chemical Biology Q1

Compare this journals

Aims and Scope

Best articles by citations

Serologic correlates of protection for evaluating the response to meningococcal vaccines

Use of attenuated paramyxoviruses for cancer therapy

Current status and future prospects for a vaccine against schistosomiasis

An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine

Time for T? Immunoinformatics addresses vaccine design for neglected tropical and emerging infectious diseases

Consultation on interactions between National Regulatory Authorities and National Immunization Technical Advisory Groups

Plant production systems for vaccines

Virus-like antigen display for cancer vaccine development, what is the potential?

Overview of mimotopes and related strategies in tumor vaccine development

In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains

Pneumococcal conjugate vaccines: emerging clinical information and its implications

Development of vaccines to prevent malaria in pregnant women: WHO MALVAC meeting report

SHOW MORE ARTICLES

Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine

Pertussis: should we improve intensive care management or vaccination strategies?

The immunization imperative

Progress in filovirus vaccine development: evaluating the potential for clinical use

Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

Norwalk virus-like particles as vaccines

Reimmunization after hematopoietic stem cell transplantation

Current status of GV1001 and other telomerase vaccination strategies in the treatment of cancer

What do the next 100 years hold for pneumococcal vaccination?

A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed

Design of tuberculosis vaccine trials under financial constraints